Skip to main content
Premium Trial:

Request an Annual Quote

Clarification: Jayakrishna Ambati

Premium
In last week’s issue of RNAi News, University of Kentucky researcher Jayakrishna Ambati was quoted as stating that he was unaware of “any independent verification” of data published in Molecular Vision by certain researchers affiliated with Opko Health (see RNAi News, 4/3/2008).
 
Ambati was referring specifically to the siRNAs evaluated in that paper and their ability to inhibit neovascularization, not siRNAs in general.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.